News for hackers. Stuff that matters.
Re:A cancer trial’s unexpected result: Remission in every pa... by elhudy on Sunday June 05, 2022 @09:42PM (#31636573)
BTK inhibitors are technically in 3rd gen (noncovalent) already if you can get in the trials (which are very promising considering they use the same mechanism).

There are no comments on this comment yet.